Literature DB >> 22390627

Tyrosyl-DNA phosphodiesterase 1 inhibitor from an anamorphic fungus.

Motoki Takagi1, Jun-ya Ueda, Ji-Hwan Hwang, Junko Hashimoto, Miho Izumikawa, Hideki Murakami, Yoshitaka Sekido, Kazuo Shin-ya.   

Abstract

Tyrosyl-DNA phosphodiesterase 1 (Tdp1) is an enzyme that catalyzes hydrolysis of 3'-phosphotyrosyl bonds and is involved in repair of irreversible topoisomerase I (Top1)-DNA covalent complexes. Tdp1 inhibitors are regarded as potential cancer therapeutics in combination with Top1 inhibitors, which are currently used to treat human cancers. While screening for Tdp1 inhibitors, we discovered a novel compound, JBIR-21 (1), from the culture of an anamorphic fungus, RF-13305. The structure of 1 was established by extensive NMR and MS analyses. Compound 1 showed inhibitory activity against Tdp1 (IC(50) value, 18 μM) and cytotoxic activity against cancer cell lines (IC(50) values, 3.5-13 μM). Compound 1 also exhibited antitumor activity in a mouse xenograft model without adverse effects.
© 2012 American Chemical Society and American Society of Pharmacognosy

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22390627     DOI: 10.1021/np2007389

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  7 in total

1.  Synthesis and biological evaluation of nitrated 7-, 8-, 9-, and 10-hydroxyindenoisoquinolines as potential dual topoisomerase I (Top1)-tyrosyl-DNA phosphodiesterase I (TDP1) inhibitors.

Authors:  Trung Xuan Nguyen; Monica Abdelmalak; Christophe Marchand; Keli Agama; Yves Pommier; Mark Cushman
Journal:  J Med Chem       Date:  2015-03-26       Impact factor: 7.446

2.  In Vitro and In Silico Studies of Human Tyrosyl-DNA Phosphodiesterase 1 (Tdp1) Inhibition by Stereoisomeric Forms of Lipophilic Nucleosides: The Role of Carbohydrate Stereochemistry in Ligand-Enzyme Interactions.

Authors:  Nadezhda S Dyrkheeva; Irina A Chernyshova; Georgy A Ivanov; Yuri B Porozov; Anastasia A Zenchenko; Vladimir E Oslovsky; Alexandra L Zakharenko; Darina I Nasyrova; Galina N Likhatskaya; Sergey N Mikhailov; Olga I Lavrik; Mikhail S Drenichev
Journal:  Molecules       Date:  2022-04-09       Impact factor: 4.927

3.  New Hydrazinothiazole Derivatives of Usnic Acid as Potent Tdp1 Inhibitors.

Authors:  Aleksander S Filimonov; Arina A Chepanova; Olga A Luzina; Alexandra L Zakharenko; Olga D Zakharova; Ekaterina S Ilina; Nadezhda S Dyrkheeva; Maxim S Kuprushkin; Anton V Kolotaev; Derenik S Khachatryan; Jinal Patel; Ivanhoe K H Leung; Raina Chand; Daniel M Ayine-Tora; Johannes Reynisson; Konstantin P Volcho; Nariman F Salakhutdinov; Olga I Lavrik
Journal:  Molecules       Date:  2019-10-15       Impact factor: 4.411

4.  Targeting Tyrosyl-DNA phosphodiesterase I to enhance toxicity of phosphodiester linked DNA-adducts.

Authors:  Evan J Brettrager; Robert C A M van Waardenburg
Journal:  Cancer Drug Resist       Date:  2019-12-19

5.  Promising New Inhibitors of Tyrosyl-DNA Phosphodiesterase I (Tdp 1) Combining 4-Arylcoumarin and Monoterpenoid Moieties as Components of Complex Antitumor Therapy.

Authors:  Tatyana M Khomenko; Alexandra L Zakharenko; Arina A Chepanova; Ekaterina S Ilina; Olga D Zakharova; Vasily I Kaledin; Valeriy P Nikolin; Nelly A Popova; Dina V Korchagina; Jóhannes Reynisson; Raina Chand; Daniel M Ayine-Tora; Jinal Patel; Ivanhoe K H Leung; Konstantin P Volcho; Nariman F Salakhutdinov; Olga I Lavrik
Journal:  Int J Mol Sci       Date:  2019-12-23       Impact factor: 5.923

Review 6.  Tyrosyl-DNA phosphodiesterases: rescuing the genome from the risks of relaxation.

Authors:  Ajinkya S Kawale; Lawrence F Povirk
Journal:  Nucleic Acids Res       Date:  2018-01-25       Impact factor: 16.971

7.  A Dual-Sensor-Based Screening System for In Vitro Selection of TDP1 Inhibitors.

Authors:  Ann-Katrine Jakobsen; Josephine Geertsen Keller; María Gonzalez; Endika Martin-Encinas; Francisco Palacios; Concepcion Alonso; Birgitta Ruth Knudsen; Magnus Stougaard
Journal:  Sensors (Basel)       Date:  2021-07-15       Impact factor: 3.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.